Pfizer’s vaccine will receive full approval from U.S. regulators on Monday

At the moment, the vaccine is used in accordance with the permission for emergency use.

The US Food and Drug Administration (FDA) will announce full approval of the Pfizer vaccine on Monday, The New York Times reports.

According to the sources of the publication, the regulatory authorities sought to complete the process by Friday. Still, they did not have time because of the need to process “a significant amount of documents and complete negotiations with the manufacturer.”

The FDA declined to comment. According to the NYT, the unofficial deadline for registration of the vaccine is September 6.

Recall that the Pfizer vaccine was approved for emergency use in December. At the moment, more than 203 million people have received it in the United States.

At the same time, none of the three vaccines used in the United States against COVID-19 has received full approval from the FDA.

As noted by Reuters, the full approval of the vaccine could be an incentive to vaccinate more Americans since it will be a confirmation that the Pfizer vaccine is safe and effective.

If you have found a spelling error, please, notify us by selecting that text and pressing Ctrl+Enter.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Author: Ivan Maltsev
The study of political and social problems of different countries of the world. Analysis of large companies on the world market. Observing world leaders in the political arena.
Function: Chief-Editor
Ivan Maltsev

Spelling error report

The following text will be sent to our editors: